Left untreated, a typical episode of major depression will run approximately ... A Cognitive-Behavioral Protocol for the Treatment of Depression. Oakland, Calif: New Harbinger Publications ...

Among the 50 states and Washington, D.C., eight have laws allowing adolescents to independently consent to mental health ...

Major depressive disorder ... remit following adequate antidepressant treatment, while most MDD patients suffer from significant core depressive or residual symptoms during their clinical course.

The wish to die is usually transient, or at least time-limited and reversible. Having a support system with an explicit plan ...

I feel like, do I want everybody to suffer with a major depressive episode for three months until ... and they're going to do an individualized treatment plan, right? And we're not quite there ...

A depressive episode can cause symptoms such as restlessness and feelings of worthlessness. Some changes to thoughts and behaviors may help improve mood and manage symptoms. Tracking triggers and ...

It is not always possible to prevent depression, but if a person knows their triggers and can recognize the start of an episode ... person does not receive treatment. Major depressive disorder ...

A major depressive episode may or may not ... problems can be both a cause and effect of bipolar episodes, making psychotherapeutic treatment important. Studies show that such treatment reduces ...

Major depressive disorder is a debilitating ... effects and might not always succeed in preventing relapses of depressive episodes. A non-pharmacological solution that could effectively treat ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for major depressive disorder, or MDD, later this year. Watertown, Mass.- ...

Relmada Therapeutics said on Wednesday its depression treatment was "unlikely" to meet the main goal of a late-stage trial based on an independent data monitoring committee's analysis, sending the ...